Evaluation of microsatellite instability testing through cell-free DNA sequencing
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz239.026
Abstract: Abstract Background Microsatellite instability (MSI) status has been approved by FDA to select for patients with metastatic tumors for cancer immunotherapy treatments. Additionally, MSI status is used in assessment of prognosis and treatment choices in… read more here.
Keywords: time employment; full part; time; illumina ... See more keywords